Submitted by Anonymous (not verified) on 22 September 2023 - 13:49
Human medicines European public assessment report (EPAR): Opfolda, miglustat, Glycogen Storage Disease Type II, Date of authorisation: 26/06/2023, Revision: 1, Status: Authorised
Source: